Glial Fibrillary Acidic Protein Is Negatively Correlated with Cognitive Outcomes in Patients with Early Relapsing Multiple Sclerosis: Year 1 Interim Analysis of the ENLIGHTEN Study of Ozanimod

Authors
Category Primary study
ConferenceACTRIMS Forum 2025
Year 2025
This article has no abstract
Epistemonikos ID: 9671fac4e21b612f968a983fcbb645a051e85356
First added on: Jan 31, 2026